Skip to content

Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound

Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02100345
Enrollment
98
Registered
2014-03-31
Start date
2014-10-31
Completion date
2017-02-28
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Endometriosis

Brief summary

Background: Endometriosis is a disease affecting 8-15 % of fertile women and is a cause of abdominal pain and suffering during women's menstrual periods. A subgroup of patients with DIE has an infiltration into the rectosigmoid bowel wall (4-37%). Knowledge of the growth pattern of rectosigmoid lesions related to subjective symptoms is mandatory in order to assess the need for follow-up with transvaginal ultrasound during medical treatment. Hypotheses: Symptoms will follow growth of rectosigmoid endometriosis. Material and methods: Two different cohorts of women, based on time of diagnosis of rectosigmoid endometriosis and treatment with hormonal intrauterine device or continuous oral contraceptives will receive a questionnaire and a transvaginal ultrasound scan (measuring size and volume) at inclusion, (6) and 12 months later. Perspectives: Patients treated conservatively may be followed by questionnaires, thereby reducing the need for time consuming clinical controls.

Interventions

None listed

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Medically treated bowel endometriosis

Exclusion criteria

* Age below 18 years * Bowel resection of any kind * Cancer

Design outcomes

Primary

MeasureTime frame
Transvaginal Ultrasound29 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026